Spyre Therapeutics, Inc. (SYRE)
85.71
+5.81
(+7.27%)
USD |
NASDAQ |
Oct 09, 16:00
85.71
0.00 (0.00%)
After-Hours: 18:21
Spyre Therapeutics 30-Day Average Daily Volume : 1.466M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.466M |
| October 07, 2026 | 1.492M |
| October 06, 2026 | 1.432M |
| October 05, 2026 | 1.312M |
| October 02, 2026 | 1.324M |
| October 01, 2026 | 1.306M |
| September 30, 2026 | 1.290M |
| September 29, 2026 | 1.251M |
| September 28, 2026 | 1.246M |
| September 25, 2026 | 1.230M |
| September 24, 2026 | 1.229M |
| September 23, 2026 | 1.201M |
| September 22, 2026 | 1.202M |
| September 21, 2026 | 1.188M |
| September 18, 2026 | 1.158M |
| September 17, 2026 | 1.061M |
| September 16, 2026 | 1.048M |
| September 15, 2026 | 1.033M |
| September 14, 2026 | 1.035M |
| September 11, 2026 | 1.019M |
| September 10, 2026 | 1.018M |
| September 09, 2026 | 1.028M |
| September 08, 2026 | 1.045M |
| September 04, 2026 | 1.026M |
| September 03, 2026 | 1.026M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.012M |
| September 01, 2026 | 986380.4 |
| August 31, 2026 | 964628.1 |
| August 28, 2026 | 925862.4 |
| August 27, 2026 | 920026.5 |
| August 26, 2026 | 926865.5 |
| August 25, 2026 | 873711.7 |
| August 24, 2026 | 935470.6 |
| August 21, 2026 | 948746.5 |
| August 20, 2026 | 940888.7 |
| August 19, 2026 | 961861.9 |
| August 18, 2026 | 964340.2 |
| August 17, 2026 | 976218.7 |
| August 14, 2026 | 992794.8 |
| August 13, 2026 | 1.007M |
| August 12, 2026 | 1.045M |
| August 11, 2026 | 1.064M |
| August 10, 2026 | 1.100M |
| August 07, 2026 | 1.220M |
| August 06, 2026 | 1.273M |
| August 05, 2026 | 1.393M |
| August 04, 2026 | 1.446M |
| August 03, 2026 | 1.512M |
| July 31, 2026 | 1.563M |
| July 30, 2026 | 1.593M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AbbVie, Inc. | 4.415M |
| Incyte Corp. | 1.595M |
| SELLAS Life Sciences Group, Inc. | 6.315M |
| Relay Therapeutics, Inc. | 3.418M |
| ACADIA Pharmaceuticals, Inc. | 2.086M |